Medical devices, healthcare technology and the business of care
510(k) clearance · K260560

Apollo TMS Therapy System;Apollo light TMS Therapy System

Mag & More GmbH · Decision date May 22, 2026

FDA DECISIONK260560

What did the FDA decide?

FDA records K260560 as a 510(k) premarket notification, with a decision dated May 22, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
May 22, 2026

FDA source record

Regulatory record facts

Identifier
K260560
Regulatory pathway
510(k) premarket notification
Product code
OBP
Decision code
SESE
Decision date
May 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Transcranial Magnetic Stimulator.

Product code
OBP
FDA device class
2

FDA decision timeline

  1. K260560 received

    Application receipt date recorded by FDA.

  2. K260560 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OBP

Product / regulatory recordCompanyPathwayDecision dateSource
Fidelity BioPharma Co.510(k) clearanceSep 6, 2026FDA
BTL-699K260691
BTL Industries, Inc.510(k) clearanceAug 23, 2026FDA
Brain Ultimate, Inc.510(k) clearanceAug 14, 2026FDA
Tonica Elektronik A/S510(k) clearanceMay 22, 2026FDA
Nexstim Oyj510(k) clearanceMar 20, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Mag & More GmbH

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Munich

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records